These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7368672

  • 21. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG, Petrun' NM, Pyrig LA, Mel'man NIa.
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract] [Full Text] [Related]

  • 22. [Features of lipid peroxidation in the blood of patients with chronic glomerulonephritis at the stage of renal dysfunction in the presence of nephrotic syndrome].
    Tugusheva FA, Kulikova AI, Zubina IM.
    Vopr Med Khim; 1993 Oct; 39(3):18-21. PubMed ID: 8333180
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of hematological findings in the diagnosis of renal diseases with special reference to abnormal morphology of the erythrocytes].
    Hashimoto K, Oba Y, Oyama H, Wajima T.
    Rinsho Byori; 1970 Nov; 18(11):774-8. PubMed ID: 5533729
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of proteinuric patients with a vegetarian soy diet and fish oil.
    Gentile MG, Fellin G, Cofano F, Delle Fave A, Manna G, Ciceri R, Petrini C, Lavarda F, Pozzi F, D'Amico G.
    Clin Nephrol; 1993 Dec; 40(6):315-20. PubMed ID: 8299238
    [Abstract] [Full Text] [Related]

  • 25. [Current state of the problem of lipid metabolism in patients with kidney diseases].
    Storozhenko AA.
    Klin Med (Mosk); 1973 Oct; 51(10):28-30. PubMed ID: 4787276
    [No Abstract] [Full Text] [Related]

  • 26. [Potassium concentration in plasma and erythrocytes in kidney patients].
    Schoeppe W, Brecht HM.
    Med Klin; 1969 Apr 25; 64(17):781-5. PubMed ID: 5785369
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
    De Castro J, Hernández-Hernández A, Rodríguez MC, Sardina JL, Llanillo M, Sánchez-Yagüe J.
    Platelets; 2007 Feb 25; 18(1):43-51. PubMed ID: 17365853
    [Abstract] [Full Text] [Related]

  • 28. [The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia].
    Gonor KV, Pogozheva AV, Kulakova SN, Medvedev FA, Miroshnichenko LA.
    Vopr Pitan; 2006 Feb 25; 75(3):17-21. PubMed ID: 16862949
    [Abstract] [Full Text] [Related]

  • 29. [Plasma complement in renal diseases in children].
    Kucharska K, Sancewicz-Pach K, Wanicka A.
    Pol Tyg Lek; 1969 Jul 28; 24(30):1155-7. PubMed ID: 5806274
    [No Abstract] [Full Text] [Related]

  • 30. [The role of tubular interstitial changes in the genesis of the rapid progression of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Shumakov VI.
    Urol Nefrol (Mosk); 1995 Jul 28; (3):7-9. PubMed ID: 7618227
    [Abstract] [Full Text] [Related]

  • 31. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I.
    Eur J Clin Pharmacol; 2002 Nov 28; 58(8):501-6. PubMed ID: 12451426
    [Abstract] [Full Text] [Related]

  • 32. [Functional status of the hemostatic and fibrinolytic systems in patients with clinical variants of chronic glomerulonephritis].
    Miagkov II, Nazar PS.
    Ter Arkh; 1989 Nov 28; 61(11):123-6. PubMed ID: 2633374
    [Abstract] [Full Text] [Related]

  • 33. [The dependence of the progression of chronic glomerulonephritis on the clinical and morphological types of glomerulonephritis and on the tubulointerstitial changes].
    Ratner MIa, Fedorova ND.
    Urol Nefrol (Mosk); 1998 Nov 28; (2):22-4. PubMed ID: 9577698
    [Abstract] [Full Text] [Related]

  • 34. [Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age].
    Ferrara P, Ruggiero A, Pulitanò S, Vacca P, Venuti L, Salvaggio E.
    Minerva Pediatr; 1998 Dec 28; 50(12):513-8. PubMed ID: 10210942
    [Abstract] [Full Text] [Related]

  • 35. [Changes in blood proteins in several kidney diseases].
    Tsykin DB, Shcherba MM.
    Urol Nefrol (Mosk); 1969 Dec 28; 34(1):18-20. PubMed ID: 5801197
    [No Abstract] [Full Text] [Related]

  • 36. [Lipid metabolism in primary and combined lesions of the kidneys in pregnant women].
    Nikulina GG, Pyrig LA, Petrun' NM, Gorelova NR.
    Vrach Delo; 1990 Jan 28; (1):28-31. PubMed ID: 2330703
    [Abstract] [Full Text] [Related]

  • 37. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV, Sokolovskaia IV, Gonchar NA.
    Ter Arkh; 1983 Jan 28; 55(6):39-41. PubMed ID: 6612619
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N, Ogbori MR, Nicman E.
    Srp Arh Celok Lek; 2002 Jan 28; 130(7-8):251-7. PubMed ID: 12585002
    [Abstract] [Full Text] [Related]

  • 39. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Jan 28; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 40. Determination of beta 1c globulin in the blood serum of children with diseases of the kidneys.
    Hager-Malecka B, Szczepański Z, Kobierska-Szczepańska A.
    Arch Immunol Ther Exp (Warsz); 1968 Jan 28; 16(6):921-6. PubMed ID: 4178558
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.